| DEC-001 |
2026-06-29 |
Document actual enrollment (900), not planned 900 |
Realistic under-enrollment; honest reporting |
RA/Biostat |
| DEC-002 |
2026-06-29 |
Right-size early-phase N (SAD 40 / MAD 40 / Ph2 240) |
Early-phase N driven by dose-levels×cohort, not power; cost/ethics (PM-003) |
Clinical/PM |
| DEC-003 |
2026-06-29 |
Ground demographics in Nemotron-Personas-Korea + T2DM prevalence |
Realistic Korean T2DM population |
Biostat |
| DEC-004 |
2026-06-29 |
Map Korean SC values to English CDISC CT |
XPORT encoding + submission standard |
DM |
| DEC-005 |
2026-06-29 |
No REMS for FDA; labeling-based risk management |
Class precedent; risks manageable by labeling |
RA-US/PV |
| DEC-006 |
2026-06-29 |
Substitute subset CDISC validator for headless Pinnacle 21 |
P21 registration-gated GUI; honest alternative + manual steps |
DM/QA |